Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-aspartyl ferritin oral solution vs iron proteinsuccinylate for iron deficiency anemia
CTR20140336Phase 3Active
- Sponsor
- Aesculapius Farmaceutici
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of acetyl-aspartyl ferritin in iron deficiency anemia (IDA), sponsored by Aesculapius Farmaceutici. Started Jun 2015; status: active.
02
Drugs
acetyl-aspartyl ferritin
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on CTR20140336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140336.